Company / Operating Income
MAXCYTE, INC. Operating Income History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$51.9M
FY2025
5-year range
-$51.9M / -$18.2M
FY2021-FY2025
Trend
-7.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -$27M to -$52M over the past 2 years.
Based on SEC 10-K filings.
-$52M in FY2025.
Declined from -$27M to -$52M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income decreased 7.4% year-over-year.
- Peak operating income was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$51.9M | -7.4% |
| FY2024 | -$48.3M | -76.5% |
| FY2023 | -$27.4M | +0.0% |
| FY2022 | -$27.4M | -50.4% |
| FY2021 | -$18.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026